All Stories

  1. Phylogenetic Characterization of Novel Reassortant 2.3.4.4b H5N8 Highly Pathogenic Avian Influenza Viruses Isolated from Domestic Ducks in Egypt During the Winter Season 2021–2022
  2. Metagenomic analysis of the gut microbiota of hooded cranes (Grus monacha) on the Izumi plain in Japan
  3. Cocirculation of Genetically Distinct Highly Pathogenic Avian Influenza H5N5 and H5N1 Viruses in Crows, Hokkaido, Japan
  4. Molecular characterization of an avian rotavirus a strain detected from a large-billed crow (Corvus macrorhynchos) in Japan
  5. Isolation and genetic characterization of multiple genotypes of both H5 and H7 avian influenza viruses from environmental water in the Izumi plain, Kagoshima prefecture, Japan during the 2021/22 winter season
  6. A lethal case of natural infection with the H5N8 highly pathogenic avian influenza virus of clade 2.3.4.4 in a mandarin duck
  7. Differential role of NSs genes in the neurovirulence of two genogroups of Akabane virus causing postnatal encephalomyelitis
  8. Stability of the Virucidal Activity of Commercial Disinfectants against Avian Influenza Viruses under Different Environmental Conditions
  9. Evaluation of the Effect of Pb Pollution on Avian Influenza Virus-Specific Antibody Production in Black-Headed Gulls (Chroicocephalus ridibundus)
  10. Newly emerged genotypes of highly pathogenic H5N8 avian influenza viruses in Kagoshima prefecture, Japan during winter 2020/21
  11. Avian paramyxovirus serotype‐1 isolation from migratory birds and environmental water in southern Japan: An epidemiological survey during the 2018/19–2021/2022 winter seasons
  12. Genetic characterization of bovine respiratory syncytial viruses in Japan between 2017 and 2019
  13. Novel RT-PCR Using Sugar Chain-Immobilized Gold-Nanoparticles Correlates Patients’ Symptoms: The Follow-Up Study of COVID-19 Hospitalized Patients
  14. Molecular characterisation of a novel avian rotavirus A strain detected from a gull species (Larus sp.)
  15. Experimental and natural infections of white-tailed sea eagles (Haliaeetus albicilla) with high pathogenicity avian influenza virus of H5 subtype
  16. The Amino Acid at Position 95 in the Matrix Protein of Rabies Virus Is Involved in Antiviral Stress Granule Formation in Infected Cells
  17. Genetic Characterization of Avian Influenza Viruses Isolated from the Izumi Plain, Japan in 2019/20 Winter Season
  18. Improved method for avian influenza virus isolation from environmental water samples
  19. Genetically Diverse Highly Pathogenic Avian Influenza A(H5N1/H5N8) Viruses among Wild Waterfowl and Domestic Poultry, Japan, 2021
  20. Prevalence and organ tropism of crane‐associated adenovirus 1 in cranes overwintering on the Izumi plain, Japan
  21. A Lethal Case of Natural Infection with the H5N8 Highly Pathogenic Avian Influenza Virus of Clade 2.3.4.4 in a Mandarin Duck
  22. Detection and molecular characterization of Babesia sp. in wild boar (Sus scrofa) from western Japan
  23. Macrocyclic peptides exhibit antiviral effects against influenza virus HA and prevent pneumonia in animal models
  24. Newly-designed primer pairs for the detection of type 2 porcine reproductive and respiratory syndrome virus genes
  25. Analyses of cell death mechanisms related to amino acid substitution at position 95 in the rabies virus matrix protein
  26. Establishment of a safe and convenient assay for detection of HA subtype-specific antibodies with PB2 gene-knockout influenza viruses
  27. Variation in the HA antigenicity of A(H1N1)pdm09-related swine influenza viruses
  28. Genetic Characterization of H5N8 Highly Pathogenic Avian Influenza Viruses Isolated from Falcated Ducks and Environmental Water in Japan in November 2020
  29. Genetic Characterization of H5N8 Highly Pathogenic Avian Influenza Viruses Isolated From Falcated Ducks and Environmental Water in Japan in November 2020
  30. Molecular detection of tick-borne protozoan parasites in sika deer (Cervus nippon) from western regions of Japan
  31. Complete Genome Sequences of Two Akabane Virus Strains Causing Bovine Postnatal Encephalomyelitis in Japan
  32. Identification of interferon-stimulated genes that attenuate Ebola virus infection
  33. Nationwide prevalence of Torque teno sus virus 1 and k2a in pig populations in Japan
  34. Mutations in the Neuraminidase-Like Protein of Bat Influenza H18N11 Virus Enhance Virus Replication in Mammalian Cells, Mice, and Ferrets
  35. Transition in genetic constellations of H3N8 and H4N6 low-pathogenic avian influenza viruses isolated from an overwintering site in Japan throughout different winter seasons
  36. Chondrosarcoma with undifferentiated neoplastic cell proliferation around the distal tibiotarsus bone in a wild Hooded Crane (<i>Grus monacha</i>)
  37. Serological survey of influenza A virus infection in Japanese wild boars ( Sus scrofa leucomystax )
  38. Identification of a distinct lineage of aviadenovirus from crane feces
  39. Development of a Model of Porcine Epidemic Diarrhea in Microminipigs
  40. Research of grasping and transporting of objects by cooperation of multiple mobile robots
  41. Phylogenetic variations of highly pathogenic H5N6 avian influenza viruses isolated from wild birds in the Izumi plain, Japan, during the 2016–17 winter season
  42. Distribution of gene segments of the pandemic A(H1N1) 2009 virus lineage in pig populations
  43. Stimulation of alpha2-adrenergic receptors impairs influenza virus infection
  44. Genetic characterization of low-pathogenic avian influenza viruses isolated on the Izumi plain in Japan: possible association of dynamic movements of wild birds with AIV evolution
  45. Genetic characterization of an avian H4N6 influenza virus isolated from the Izumi plain, Japan
  46. Identification and molecular characterization of novel primate bocaparvoviruses from wild western lowland gorillas of Moukalaba-Doudou National Park, Gabon
  47. Antigenic diversity of H5 highly pathogenic avian influenza viruses of clade 2.3.4.4 isolated in Asia
  48. Characterization of Highly Pathogenic Avian Influenza Virus A(H5N6), Japan, November 2016
  49. Nationwide Distribution of Bovine Influenza D Virus Infection in Japan
  50. Molecular epidemiological study of adenovirus infecting western lowland gorillas and humans in and around Moukalaba-Doudou National Park (Gabon)
  51. Isolation and molecular characterization of porcine epidemic diarrhea viruses collected in Japan in 2014
  52. Selection of antigenically advanced variants of seasonal influenza viruses
  53. IRES-mediated translation of foot-and-mouth disease virus (FMDV) in cultured cells derived from FMDV-susceptible and -insusceptible animals
  54. Amino acid changes in PB2 and HA affect the growth of a recombinant influenza virus expressing a fluorescent reporter protein
  55. Contribution of the interaction between the rabies virus P protein and I-kappa B kinase ϵ to the inhibition of type I IFN induction signalling
  56. Isolation and characterization of influenza A viruses from environmental water at an overwintering site of migratory birds in Japan
  57. Full genome sequences of torque teno sus virus strains that coinfected a pig with postweaning multisystemic wasting syndrome in Japan: implications for genetic diversity
  58. Molecular Determinants of Virulence and Stability of a Reporter-Expressing H5N1 Influenza A Virus
  59. Genetic and serological surveillance for non-primate hepacivirus in horses in Japan
  60. Mutations in influenza A virus during amantadine-oseltamivir combination therapy
  61. A Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia
  62. Identification of mammalian-adapting mutations in the polymerase complex of an avian H5N1 influenza virus
  63. Genetic diversity of highly pathogenic H5N8 avian influenza viruses at a single overwintering site of migratory birds in Japan, 2014/15
  64. Multi-spectral fluorescent reporter influenza viruses (Color-flu) as powerful tools for in vivo studies
  65. Efficient Isolation of Swine Influenza Viruses by Age-Targeted Specimen Collection
  66. Detection sensitivity of influenza rapid diagnostic tests
  67. Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine
  68. B-Cell-Intrinsic Hepatitis C Virus Expression Leads to B-Cell-Lymphomagenesis and Induction of NF-κB Signalling
  69. Recent insights into hepatitis B virus-host interactions
  70. A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus
  71. Characterization of H7N9 influenza A viruses isolated from humans
  72. A Novel Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice from Pandemic H1N1 and Highly Pathogenic H5N1 Virus Challenges
  73. Genomic polymorphisms in 3β-hydroxysterol Δ24-reductase promoter sequences
  74. Synergistic Effect of the PDZ and p85 -Binding Domains of the NS1 Protein on Virulence of an Avian H5N1 Influenza A Virus
  75. A cell-based screening system for influenza A viral RNA transcription/replication inhibitors
  76. Cross Talk Between Animal and Human Influenza Viruses
  77. Intrinsic Temperature Sensitivity of Influenza C Virus Hemagglutinin-Esterase-Fusion Protein
  78. Intrinsic Temperature Sensitivity of Influenza C Virus Hemagglutinin-Esterase-Fusion Protein
  79. Competitive Incorporation of Homologous Gene Segments of Influenza A Virus into Virions
  80. Characterization In Vitro and In Vivo of Pandemic (H1N1) 2009 Influenza Viruses Isolated from Patients
  81. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets
  82. A Replication-Incompetent PB2-Knockout Influenza A Virus Vaccine Vector
  83. Reverse Genetics of Influenza Viruses
  84. Taming influenza viruses
  85. The Highly Conserved Arginine Residues at Positions 76 through 78 of Influenza A Virus Matrix Protein M1 Play an Important Role in Viral Replication by Affecting the Intracellular Localization of M1
  86. Avian-Type Receptor-Binding Ability Can Increase Influenza Virus Pathogenicity in Macaques
  87. In vitro selection of influenza B viruses with reduced sensitivity to neuraminidase inhibitors
  88. Replication-incompetent influenza A viruses that stably express a foreign gene
  89. Mutations in PA, NP, and HA of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice
  90. Subclinical Brain Injury Caused by H5N1 Influenza Virus Infection
  91. Effect of an Asparagine-to-Serine Mutation at Position 294 in Neuraminidase on the Pathogenicity of Highly Pathogenic H5N1 Influenza A Virus
  92. Impact of Amino Acid Mutations in PB2, PB1-F2, and NS1 on the Replication and Pathogenicity of Pandemic (H1N1) 2009 Influenza Viruses
  93. Frequency of Drug-resistant Viruses and Virus Shedding in Pediatric Influenza Patients Treated With Neuraminidase Inhibitors
  94. A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection
  95. Characterization of Oseltamivir-Resistant 2009 H1N1 Pandemic Influenza A Viruses
  96. Biological and Structural Characterization of a Host-Adapting Amino Acid in Influenza Virus
  97. High Level of Genetic Compatibility between Swine-Origin H1N1 and Highly Pathogenic Avian H5N1 Influenza Viruses
  98. Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans between 2003 and 2008 in northern Vietnam
  99. Sensitivity of Influenza Rapid Diagnostic Tests to H5N1 and 2009 Pandemic H1N1 Viruses
  100. Significance of Seasonal Influenza Viruses in the Stool of Pediatric Patients
  101. Efficacy of the New Neuraminidase Inhibitor CS-8958 against H5N1 Influenza Viruses
  102. T-705 (favipiravir) activity against lethal H5N1 influenza A viruses
  103. Ostrich Involvement in the Selection of H5N1 Influenza Virus Possessing Mammalian-Type Amino Acids in the PB2 Protein
  104. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses
  105. Incorporation of influenza A virus genome segments does not absolutely require wild-type sequences
  106. Region Required for Protein Expression from the Stop-Start Pentanucleotide in the M Gene of Influenza B Virus
  107. Selection of H5N1 Influenza Virus PB2 during Replication in Humans
  108. Mutational Analysis of Conserved Amino Acids in the Influenza A Virus Nucleoprotein
  109. Nucleotide Sequence Requirements at the 5′ End of the Influenza A Virus M RNA Segment for Efficient Virus Replication
  110. An Adenovirus Vector-Mediated Reverse Genetics System for Influenza A Virus Generation
  111. Contributions of Two Nuclear Localization Signals of Influenza A Virus Nucleoprotein to Viral Replication
  112. Influenza Pandemic
  113. Identification and Characterization of Peptides Binding to Newcastle Disease Virus by Phage Display